From Europe. For the global patent community.
Trending Topics:
JUVE Patent Pharmaceuticals

Pharmaceuticals

Cases
Supplementary protection certificates

CJEU to decide if authorisation for human drug precludes SPC for veterinary use

Can a veterinary product authorisation be considered the first market authorisation if the active ingredient was previously approved for human use? The German Federal Patent Court has referred this qu ...

20 January 2026 by Konstanze Richter
Sponsored Content Patents

Lessons from dapagliflozin in the UK: status and effects of “hold the ring” injunctions

The UK has again been at the forefront of European pharmaceutical patent litigation between generics and patentees, with the proceedings between Astra ...

29 January 2026 by Pinsent Masons LLP
Cases
Cardiovascular drug

Novartis and Freshfields defend Entresto at Dutch Court of Appeal

Novartis has successfully defended against an attack on its SPC protecting a treatment for chronic heart failure in the Netherlands. The Court of Appe ...

12 January 2026 by Konstanze Richter
Cases
Blockbuster drug

Regional Court Munich grants PI to Regeneron against generics in Eylea case

Once again, Regeneron and Bayer have successfully defended their ophthalmic drug Eylea on the German market and beyond. Munich Regional Court yesterda ...

9 January 2026 by Konstanze Richter
Cases
Parkinson's drug

The Hague upholds sales ban on Vivanta's generic safinamide product

Vivanta is still barred from marketing its generic version of the Parkinson's treatment Xadago in the Netherlands. The District Court The Hague has up ...

5 January 2026 by Konstanze Richter
Sponsored Content Damages in the Unified Patent Court: Jurisdiction, Procedure, and Future Directions

The Unified Patent Court and Damages: Broad Powers, Procedural Flexibility, and the Road Ahead

The Unified Patent Court (UPC) is developing a reputation as an injunction-centric forum, but its broad powers and procedural flexibility for awarding ...

17 December 2025 by Simmons + Simmons LLP
Sponsored Content SPCs

The SPC Manufacturing Waiver: competition through certainty?

The SPC Manufacturing Waiver was introduced just over six years ago, aiming to create a level playing field between EU and non-EU generics and biosimi ...

17 December 2025 by Pinsent Masons LLP
Cases
Second medical use

Generics succeed against Sanofi over cancer drug cabazitaxel

Several generic drug companies scored a win at the UPC against Sanofi's second medical use patent for cabazitaxel. In a decision issued today, the loc ...

12 December 2025 by Konstanze Richter
Cases
MS drug

Boards of Appeal revoke Biogen's dosage patent for Tecfidera

The Boards of Appeal at the European Patent Office have refused to grant Biogen's dosage patent EP 873, which is central to its multiple sclerosis dru ...

12 December 2025 by Mathieu Klos
People & Business
UK

Marks & Clerk grows IP offering with Potter Clarkson partner

Nick McDonald has joined Marks & Clerk's London office as partner. He was previously partner at mixed firm Potter Clarkson, where he litigated pre ...

9 December 2025 by Mathieu Klos
Cases
Cancer drug

Halozyme and Quinn Emanuel secure PI against MSD over Keytruda SC

Merck Sharp & Dohme cannot launch Keytruda SC in Germany following a preliminary injunction issued by Munich Regional Court. Halozyme has thus pre ...

8 December 2025 by Mathieu Klos
Sponsored Content Inventive Step and Claim Interpretation in Pharmaceutical Patents: UPC and EPO Approaches

Divergent Approaches, Consistent Outcomes: UPC and EPO Tackle Inventive Step in Amgen’s Patent Case

The Amgen v Sanofi and Regeneron dispute marks the first central revocation case before the Unified Patent Court (UPC), with the Court of Appeal rever ...

4 December 2025 by Simmons + Simmons LLP
Cases
Cholesterol-lowering drugs

Amgen prevails over Sanofi at UPC Court of Appeal with Brinkhof and Bardehle

Amgen's most important cholesterol-lowering patent EP 797 is valid after all, according to a landmark ruling by the UPC Court of Appeal yesterday. The ...

26 November 2025 by Mathieu Klos
Cases
Multiple sclerosis drug

Merz fails with PI request in first-ever SPC case against Viatris

The first attempt to obtain a PI against the generic multiple sclerosis drug Fampridin Viatris in France has failed. Merz had applied for the PI in th ...

25 November 2025 by Mathieu Klos
Cases
Parkinson's drug

Dutch court surprises with swift decision on Newron’s SPC for Xadago

The District Court The Hague issued a provisional injunction at a hearing in an unusually swift and clear decision. This marks another chapter in the ...

18 November 2025 by Christina Schulze
Sponsored Content Unified Patent Court

Arbitration and the UPC: A New Avenue for Resolving FRAND and Life Sciences Patent Disputes?

The role of arbitration in resolving patent disputes has often been viewed as being limited to damages assessments or determining FRAND licensing rate ...

13 November 2025 by Pinsent Masons LLP
Popular